EWA
CANF

EverSource Wealth Advisors’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

EverSource Wealth Advisors’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$14 – 4404
2025
Q4 		$14 Hold
3
– – ﹤0.01% 4237
2025
Q3 		$42 Buy
+3
New +$46 ﹤0.01% 4264

Other funds holding CANF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EverSource Wealth Advisors's CANF Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026, closing a stake of 3 shares — an estimated $14 sold.

EverSource Wealth Advisors first reported a position in CANF in Q3 2025 and held it in 2 quarters. The position peaked at $42 in Q3 2025. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

  • EverSource Wealth Advisors reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 3 Can-Fite BioPharma American Depositary Shares shares in Q1 2026, an estimated $14.
  • EverSource Wealth Advisors first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2025 and held it in 2 quarters.
  • EverSource Wealth Advisors's Can-Fite BioPharma American Depositary Shares position peaked at $42 in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.